Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide.
about
Single-gene disorders: what role could moonlighting enzymes play?Scale-free flow of life: on the biology, economics, and physics of the cellThe crystal structure of a multifunctional protein: phosphoglucose isomerase/autocrine motility factor/neuroleukinThe 3-D Structural Basis for the Pgi Genotypic Differences in the Performance of the Butterfly Melitaea cinxia at Different TemperaturesThe crystal structure of rabbit phosphoglucose isomerase complexed with 5-phospho-D-arabinonohydroxamic acid.Raft-dependent endocytosis of autocrine motility factor/phosphoglucose isomerase: a potential drug delivery route for tumor cellsIsolation of novel animal cell lines defective in glycerolipid biosynthesis reveals mutations in glucose-6-phosphate isomerase.Metabolic genes in cancer: their roles in tumor progression and clinical implicationsPhosphoglucose isomerase/autocrine motility factor mediates epithelial and mesenchymal phenotype conversions in breast cancer.Autocrine motility factor modulates EGF-mediated invasion signaling.Silencing of autocrine motility factor induces mesenchymal-to-epithelial transition and suppression of osteosarcoma pulmonary metastasis.Carbohydrate metabolism in Archaea: current insights into unusual enzymes and pathways and their regulation.Glycolysis, tumor metabolism, cancer growth and dissemination. A new pH-based etiopathogenic perspective and therapeutic approach to an old cancer questionTP53 mutation hits energy metabolism and increases glycolysis in breast cancer.Exploiting unique structural and functional properties of malarial glycolytic enzymes for antimalarial drug developmentPhosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells.Increased migration of human mesenchymal stromal cells by autocrine motility factor (AMF) resulted in enhanced recruitment towards hepatocellular carcinoma.Bacterial virulence in the moonlight: multitasking bacterial moonlighting proteins are virulence determinants in infectious diseaseGlucose-6-phosphate isomerase promotes the proliferation and inhibits the apoptosis in fibroblast-like synoviocytes in rheumatoid arthritis.Evodiamine Induces Apoptosis and Inhibits Migration of HCT-116 Human Colorectal Cancer CellsSilencing of phosphoglucose isomerase/autocrine motility factor decreases U87 human glioblastoma cell migration.Probing the location and function of the conserved histidine residue of phosphoglucose isomerase by using an active site directed inhibitor N-bromoacetylethanolamine phosphateAMF/PGI-mediated tumorigenesis through MAPK-ERK signaling in endometrial carcinomaAnticancer agents that counteract tumor glycolysis.The crystal structure of rabbit phosphoglucose isomerase complexed with D-sorbitol-6-phosphate, an analog of the open chain form of D-glucose-6-phosphateCrystallization and preliminary X-ray characterization of phosphoglucose isomerase from Mycobacterium tuberculosis H37Rv.Localization of autocrine motility factor receptor to caveolae and clathrin-independent internalization of its ligand to smooth endoplasmic reticulum.Enzymatic function of multiple origins regulates the progression of colorectal cancer and the development of metastases.Expression of genes encoding for proteins involved in heparan sulphate and chondroitin sulphate chain synthesis and modification in normal and malignant plasma cellsGlucose-6-Phosphate Isomerase (G6PI) Mediates Hypoxia-Induced Angiogenesis in Rheumatoid Arthritis.How does cancer cell metabolism affect tumor migration and invasion?Hypoxia enhances the expression of autocrine motility factor and the motility of human pancreatic cancer cellsHigh affinity glycosaminoglycan and autoantigen interaction explains joint specificity in a mouse model of rheumatoid arthritisGlucose metabolic phenotype of pancreatic cancer.New views on the selection acting on genetic polymorphism in central metabolic genes.Targeting of several glycolytic enzymes using RNA interference reveals aldolase affects cancer cell proliferation through a non-glycolytic mechanism.Hyperthermia reduces migration of osteosarcoma by suppression of autocrine motility factor.Novel type of glucose-6-phosphate isomerase in the hyperthermophilic archaeon Pyrococcus furiosus.Phosphoglucose isomerase/autocrine motility factor promotes melanoma cell migration through ERK activation dependent on autocrine production of interleukin-8Autocrine motility factor stimulates the invasiveness of malignant cells as well as up-regulation of matrix metalloproteinase-3 expression via a MAPK pathway.
P2860
Q24530918-66813A8F-3B43-4574-BA92-40ABE53E6527Q24658445-87430516-9590-456A-9775-DADA023A4524Q24683286-1F05F08A-DC1A-41E8-87C7-A7972C50C8B3Q27332304-DA575D94-115F-4E77-8B9B-6DD026C4C6B7Q27638924-CB7221BB-137D-4AF2-B6A4-BFD0722C8306Q28473988-96F1C1D7-7FF4-4067-9053-DE4B0F56A2D6Q33569838-41408BD1-36F6-4CA5-ADAB-70E990755EC0Q33772469-BAC50C1F-3BFC-4BAA-BAAF-FD0FC157273FQ33871988-ED9667DD-15CB-45B8-B819-E9AD83556218Q33881000-C52E0148-62B5-4621-8938-F6B364F3A222Q34316283-60FCDDF2-76E5-4584-AD9C-518688B33090Q34408562-CA3A6B7F-260B-4359-88A5-F00B9BB8B565Q34459681-C8A6D3D3-0838-46EA-AF73-31FE876EE2F3Q34539146-EC469F6A-949B-4195-8FCA-D668338AACC1Q34792277-38B1BEC9-7555-42D8-9406-F99849F003EEQ34899974-5028E152-F44A-4742-BF0E-2F1E3903D138Q35149319-FED5C9D9-4D9D-4444-B73B-DCD8A9E40466Q35191900-DD36694F-BFC3-4A6B-8C4E-5809E3F9A00CQ35577276-5C08A973-8FCA-442D-A5F5-3533EDAC2315Q35845158-72764FF6-5D94-4737-81D0-714573BE15F3Q35943863-E4601C5C-497C-452F-9C1A-F8BE16494DD0Q36281333-6CF06A15-111B-4DE2-89AC-1D33ABCE0585Q36413463-51B192BC-F504-4693-A6FA-5D7D2419C323Q36452381-2537F1F0-A1E7-493B-BB5A-56307C7BD91EQ36517981-9184655E-FB11-4632-9895-0E406DF173D1Q36580641-6BF961F9-8A03-41D4-B4A7-D2B6D60D8619Q36888191-4D6FC62C-8BB1-472E-867D-69A16D5A67A4Q37078275-D494C77C-BA93-405E-A833-53BC4DBE2DF4Q37314430-F4415A7C-2322-4EC3-B28B-22241355A156Q37571042-EDAD62EA-530D-472B-B852-86844A36E478Q38153177-5ADEE4E4-5842-4ABE-AD59-718B4DF98B54Q38283699-30EE2005-2869-4B90-B727-E027FA056D33Q38359753-97F856A6-B3EC-4C90-AF2B-07F80AF50479Q38791962-6C45DF4B-A78C-4F8C-BBA0-17FF6ABA7F10Q39012239-F42DAD2A-D871-4AD1-A182-BBDC77287B33Q39254305-F0529DB0-07DC-4FF0-B911-75C762282D93Q39268116-65613BD8-1520-47EF-8D70-F7D3F68BD7F8Q39527213-E86ACA1B-8D87-4ECB-91A8-3C739D634C81Q39791767-71672BAF-48FE-4366-A437-6FAB389DC3F4Q39981245-003B11C1-7576-4896-B096-8D1847C4C35B
P2860
Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide.
description
1996 nî lūn-bûn
@nan
1996 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Tumor cell autocrine motility ...... ohexose isomerase polypeptide.
@ast
Tumor cell autocrine motility ...... ohexose isomerase polypeptide.
@en
Tumor cell autocrine motility ...... ohexose isomerase polypeptide.
@nl
type
label
Tumor cell autocrine motility ...... ohexose isomerase polypeptide.
@ast
Tumor cell autocrine motility ...... ohexose isomerase polypeptide.
@en
Tumor cell autocrine motility ...... ohexose isomerase polypeptide.
@nl
prefLabel
Tumor cell autocrine motility ...... ohexose isomerase polypeptide.
@ast
Tumor cell autocrine motility ...... ohexose isomerase polypeptide.
@en
Tumor cell autocrine motility ...... ohexose isomerase polypeptide.
@nl
P2093
P1433
P1476
Tumor cell autocrine motility ...... ohexose isomerase polypeptide.
@en
P2093
P304
P407
P577
1996-07-01T00:00:00Z